STERIS Corporation to acquire Xodus Medical, Inc.

STERIS Corporation has agreed to acquire Xodus Medical, Inc. in a strategic transaction valued at two billion US dollars. The healthcare deal was announced on 11 October 2026. STERIS, which is based in Ireland, will purchase the United States based target. The consideration for the acquisition consists of cash and an earn-out component. This structure allows for a portion of the total value to be contingent on future performance metrics, although specific details regarding the earn-out conditions are not provided in the available data. The transaction represents a significant move within the healthcare sector, combining the capabilities of the Irish buyer with the assets of the American target. Both parties have confirmed their intent to proceed with the merger. The deal is currently at the firm intention stage, indicating a strong commitment to closing the transaction. No completion date has been reported yet. The transaction is subject to customary closing conditions and regulatory approval.